Experience

• 

  Penn medicine lancaster general health

  Sept 2001 - May 2002

  Hospital-based clinical research/computational biology

  Clinical research and computational biology under the supervision of Marguerite Duane MD and David Verrier PhD. Designed and coded a quantitative pattern-recognition software to identify, predict, and (hopefully) eradicate specific recessive genetic disorders in local Amish communities.

• 

  Medical school

  Sept 2004 - Jan 2006

  Medical student

  Left medical school upon discovery of a pricing flaw in the bid-ask spreads of early, high-latency electronic derivative markets. Invented multiple autonomous and algorithmic protocols during this period.

• 

  Morgan stanley

  Jan 2006 - Jan 2009

  Derivative arbitrage

  Series 31 (Futures/Derivatives Exam)Rule 144A (Restricted Securities Exam)Series 7 (Securities Exam)Series 66 (Securities Advisor Exam)

• 

  Private equity

  Jan 2009 - now

  Alternative investments

  Media Technology; RFID/QR CodesLanguage Translation EarbudsWaverly Labs Inc.In-Stadium Advertising; Naming RightsMunicipal Bonds; Stadium FinancingRevenue Bonds; Airport FinancingIntellectual Property; Music/PublishingMachine Learning in Music Taste PredictionBlockchain Smart Contracts/TokenomicsAutonomous Self-Checkout Touchscreen Concierge KiosksAd Distribution Networks/Software

• 

  Billboards.com

  Sept 2023 - now

  Ceo at billboards.com

  Building the infrastructure; connecting the hardware; writing the software; developing the platform; inventing the sensors; mining the data; and coding the Generative AI; to underpin the $64 Billion annual global billboard market.